Mitkov M, Pekhlivanov B, Terzieva D
Akush Ginekol (Sofiia). 2004;43(3):34-7.
The aim of our study was to compare the effect of Metformin applied independently to the effect of Metformin used in combination with Diane35, the latter given only during the first two months of the treatment.
In this prospective, open clinical study, 30 women with PCOS were included, divided in two groups 15 women each. Group 1 received 850 mg Metformin twice a day and group 2 in which Diane35 was added to the same treatment only during the first two months of the investigation. In addition the following tests have been made--immune reactive insulin, total testosterone, SHBG, free androgen index, anthropometric and some biochemical indices.
Much better decreasing of the level of testosterone and free androgen index in group 2, without worsening of the anthropometric and biochemical indices.
The combination of Metformin with the intermittent application of Diane35 is an appropriate alternative for the pathogenic influence and clinical improvement of the symptoms of androgen excess in cases with PCOS.
我们研究的目的是比较单独使用二甲双胍与二甲双胍联合达英35(后者仅在治疗的前两个月使用)的效果。
在这项前瞻性、开放性临床研究中,纳入了30名多囊卵巢综合征女性,分为两组,每组15名女性。第1组每天两次服用850毫克二甲双胍,第2组在研究的前两个月在相同治疗基础上加用达英35。此外,还进行了以下检测——免疫反应性胰岛素、总睾酮、性激素结合球蛋白、游离雄激素指数、人体测量指标和一些生化指标。
第2组睾酮水平和游离雄激素指数下降得更好,且人体测量指标和生化指标没有恶化。
二甲双胍与间歇性使用达英35联合应用是多囊卵巢综合征患者雄激素过多症状的致病影响和临床改善的合适替代方案。